Dow Jones Top Company Headlines at 3 AM ET: Sino Biopharm Strikes Drug Licensing Deal With AstraZeneca, Deepens GSK Partnership | White ...

Dow Jones top company headlines highlighted multiple deals and market moves, starting with Sino Biopharmaceutical’s agreement with AstraZeneca to license a drug. Sino Biopharmaceutical will receive $200 million upfront and could qualify for milestone payments, while also deepening its partnership with GSK. In other corporate news, GM-backed Momenta made a muted debut in Hong Kong after its $751 million IPO, with shares up 2.8% from the IPO price amid caution about self-driving profitability. Coty is set to transfer the Gucci Beauty license back to Kering ahead of schedule, with Kering expecting licensing to L’Oréal in mid-2027 under a 50-year agreement. Amazon returned to the bond market with a multitranche offering as borrowing costs remain low, while SpaceX shares slipped in their Nasdaq-100 debut.